Doctor profile · Federal record
Dr. MATTHEW LAROE, M.D.
Endocrinology, Diabetes & Metabolism Physician (CMS: ENDOCRINOLOGY) · MIDLOTHIAN, VA
- NPI 1598290454
- Accepts Medicare
- 9 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
348 BROWNS HILL CT
MIDLOTHIAN, VA 231149511
(804) 272-2702
fax (804) 272-9355
Credentials & registration
- NPI registered
- April 2017 — 9 yrs on file
- Profile last updated
- February 27, 2023
- Year of graduation
- 2017 — 9 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- Virginia #0101275228
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1598290454. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,866
Distinct HCPCS
10
Medicare allowed
$228,891
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 2,160 | 24 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 835 | 390 | $124 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 266 | 266 | $175 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 190 | 79 | $34 | |
82962 |
Blood glucose (sugar) test performed by hand-held instrument | 186 | 120 | $3 | |
77080 |
Dxa bone density measurement of hip, pelvis, spine | 67 | 67 | $37 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 63 | 63 | $208 | |
96372 |
Injection of drug or substance under skin or into muscle | 42 | 25 | $14 | |
76536 |
Ultrasound scan of head and neck soft tissue | 35 | 35 | $111 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 22 | 22 | $88 |
In context: peer comparison
Among 7 peers in this city , average services per provider: 321. This provider delivers 12× the peer median.Open Payments
Industry payments received
All-time total
$2,507
Transactions
93
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Insulet Corporation | 7 | $675.39 | |
| Lilly USA, LLC | 21 | $372.42 | |
| Novo Nordisk Inc | 24 | $336.45 | |
| SANOFI-AVENTIS U.S. LLC | 6 | $146.29 | |
| Abbott Laboratories | 5 | $97.38 | |
| Xeris Pharmaceuticals, Inc. | 4 | $84.35 | |
| Novartis Pharmaceuticals Corporation | 4 | $81.87 | |
| Radius Health, Inc. | 3 | $77.04 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $73.89 | |
| Antares Pharma, Inc. | 3 | $58.60 | |
| Amneal Pharmaceuticals LLC | 3 | $54.56 | |
| Tolmar, Inc. | 3 | $45.69 | |
| IBSA Pharma Inc. | 2 | $43.99 | |
| PFIZER INC. | 2 | $41.77 | |
| Mannkind Corporation | 2 | $41.54 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,093
Patients
692
Total drug cost
$879,561
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 364 | 124 | $5,833 |
| Metformin Hcl Er (Metformin Hcl) | Brand | 227 | 80 | $3,593 |
| Glimepiride | Generic | 200 | 66 | $3,759 |
| Ozempic (Semaglutide) | Brand | 183 | 52 | $320,613 |
| Atorvastatin Calcium | Generic | 153 | 56 | $2,863 |
| Rosuvastatin Calcium | Generic | 128 | 47 | $3,621 |
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 125 | 48 | $123,941 |
| Synthroid (Levothyroxine Sodium) | Brand | 120 | 40 | $11,173 |
| Jardiance (Empagliflozin) | Brand | 113 | 41 | $165,147 |
| Methimazole | Generic | 105 | 32 | $1,285 |